Sc. Murray et al., REGULATION OF GRANULOSA CELL-DERIVED OVARIAN METALLOPROTEINASE INHIBITOR(S) BY PROLACTIN, Journal of Reproduction and Fertility, 107(1), 1996, pp. 103-108
Increased prolactin concentrations are known to inhibit the ovarian pr
oteolytic enzyme cascade associated with follicular rupture. It is not
known whether there is also an effect of prolactin on endogenous prot
einase inhibitors such as the tissue inhibitors of metalloproteinases
(TIMPs). We sought to study the effect of prolactin on ovarian metallo
proteinase inhibitors in cultured rat granulosa cells. Granulosa cells
were cultured for 24 h with prolactin (0-1000 ng ml(-1)) in the absen
ce or presence of LH. Metalloproteinase inhibitor activity in the cond
itioned culture media was measured by a colorimetric assay. Prolactin
at 1000 ng ml(-1) increased inhibitor activity by 2.86 +/- 0.63 times.
Expression of mRNA encoding TIMP-1 measured by Northern analysis incr
eased by 2.34 +/- 0.34 times with 100 ng prolactin ml(-1) and by 2.43
+/- 0.42 times with 1000 ng prolactin ml(-1) compared with control cul
tures (no LH, no prolactin). In the presence of LH, expression of mRNA
encoding TIMP-1 and inhibitor activity increased by 2.60 +/- 0.6 and
4.60 +/- 0.54 times, respectively. However, no further change in mRNA
expression or inhibitor activity was apparent with the addition of pro
lactin to LH-treated cultures. Prolactin had no effect on expression o
f mRNA encoding TIMP-3 in the absence or presence of LH, although LH s
timulated a 1.7-fold increase in mRNA encoding TIMP-3 compared with co
ntrols. Addition of prolactin had no effect on media concentrations of
oestradiol or progesterone. These data demonstrate that metalloprotei
nase inhibitor activity increases with increasing doses of prolactin;
however, when LH was added this effect was no longer seen. With an inc
rease in metalloproteinase inhibitor activity, tissue metalloproteinas
e action could be decreased, providing a possible explanation for the
local inhibition on pre- and peri-ovulatory pathways by hyperprolactin
aemia.